Vycor Medical, Inc.
VYCO
$0.0648
-$0.0041-5.95%
| Weiss Ratings | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.57 | |||
| Price History | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -6.09% | |||
| 60-Day Total Return | -7.30% | |||
| 90-Day Total Return | -33.88% | |||
| Year to Date Total Return | -7.30% | |||
| 1-Year Total Return | -27.19% | |||
| 2-Year Total Return | -30.47% | |||
| 3-Year Total Return | -64.00% | |||
| 5-Year Total Return | 54.29% | |||
| 52-Week High % Change | -49.35% | |||
| 52-Week Low % Change | 99.31% | |||
| Price | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.13 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Jun 20, 2024 | |||
| 52-Week High Price (Date) | May 23, 2024 | |||
| Valuation | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.16M | |||
| Enterprise Value | 3.09M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | 19.70% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.48 | |||
| Price/Book (Q) | -0.59 | |||
| Enterprise Value/Revenue (TTM) | 2.14 | |||
| Price | $0.06 | |||
| Enterprise Value/EBITDA (TTM) | -101.54 | |||
| Enterprise Value/EBIT | -33.37 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 32.90M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 558 2000 | |||
| Address | 951 Broken Sound Boulevard Boca Raton, FL 33487 | |||
| Website | www.vycormedical.com | |||
| Country | United States | |||
| Year Founded | 2005 | |||
| Profitability | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -6.41% | |||
| Profit Margin | -13.41% | |||
| Management Effectiveness | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -5.43% | |||
| Return on Equity | -- | |||
| Income Statement | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.44M | |||
| Total Revenue (TTM) | 1.44M | |||
| Revenue Per Share | $0.04 | |||
| Gross Profit (TTM) | 1.29M | |||
| EBITDA (TTM) | -30.40K | |||
| EBIT (TTM) | -92.50K | |||
| Net Income (TTM) | -193.50K | |||
| Net Income Avl. to Common (TTM) | -193.50K | |||
| Total Revenue Growth (Q YOY) | 26.67% | |||
| Earnings Growth (Q YOY) | -16.12% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -1.52% | |||
| Balance Sheet | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 157.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 743.40K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -3.68M | |||
| Current Ratio (Q) | 0.163 | |||
| Book Value Per Share (Q) | -$0.11 | |||
| Total Assets (Q) | 1.07M | |||
| Total Current Liabilities (Q) | 4.55M | |||
| Total Debt (Q) | 1.08M | |||
| Total Liabilities (Q) | 4.76M | |||
| Total Common Equity (Q) | -3.68M | |||
| Cash Flow | VYCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.20K | |||
| Cash from Financing (TTM) | -5.10K | |||
| Net Change in Cash (TTM) | 88.50K | |||
| Levered Free Cash Flow (TTM) | 425.90K | |||
| Cash from Operations (TTM) | 103.90K | |||
